Загрузка...
Management of hair loss associated with endocrine therapy in patients with breast cancer: an overview
Endocrine therapy-induced hair loss (ETIHL) associated with aromatase inhibitors and tamoxifen treatment is currently mostly reported but remained an unresolved therapeutic issue in patients with breast cancer (BC) since the number of studies regarding the management is limited in literature. Herein...
Сохранить в:
| Опубликовано в: : | Springerplus |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Springer International Publishing
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4864803/ https://ncbi.nlm.nih.gov/pubmed/27247882 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40064-016-2216-3 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|